Cannabidiol (CBD) Found to Reduce Seizure Frequency in Phase III Trial

 Photo Credit: The Daily Chronic

Photo Credit: The Daily Chronic

According to a placebo-controlled and randomized trial published in The New England Journal of Medicine, orally administered CBD reduces the frequency of seizures in children with severe forms of epilepsy. A team of researchers from the United States and England looked over the effects of pharmaceutical grade standardized CBD extracts in comparison to placebo and reported, "The median frequency of convulsive seizures per month decreased from 12.4 to 5.9 with cannabidiol, as compared with a decrease from 14.9 to 14.1 with placebo." The study involved 120 children and young adults with treatment resistant Dravet syndrome, but a subsequent study involving patients with Lennox-Gastaut syndrome yielded similar results.

This information has been provided by the Daily Chronic and approved by our Chief Medical Officer.